Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'cholinesterase inhibitors' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 185 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Doody, RS; Dunn, JK; Clark, CM; Farlow, M; Foster, NL; Liao, T; Gonzales, N; Lai, E; Massman, P
      Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    2. Broadley, KJ; Kelly, DR
      Muscarinic receptor agonists and antagonists

      MOLECULES
    3. Lamb, HM; Goa, KL
      Rivastigmine - A pharmacoeconomic review of its use in Alzheimer's disease

      PHARMACOECONOMICS
    4. Sanchez-Amate, MC; Flores, P; Sanchez-Santed, F
      Effects of chlorpyrifos in the plus-maze model of anxiety

      BEHAVIOURAL PHARMACOLOGY
    5. Rodrigues, TC; Tubino, M; Godinho, OES; Neto, GD
      Flow-injection spectrophotometric determination of paraoxon by its inhibitory effect on the enzyme acetylcholinesterase

      ANALYTICAL SCIENCES
    6. Post, SG; Stuckey, FC; Whitehouse, PJ; Ollerton, S; Durkin, C; Robbins, D; FallCreek, SJ
      A focus group on cognition-enhancing medications in Alzheimer disease: Disparities between professionals and consumers

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    7. Bartolucci, C; Perola, E; Pilger, C; Fels, G; Lamba, D
      Three-dimensional structure of a complex of galanthamine (Nivalin (R)) with acetylcholinesterase from Torpedo californica: Implications for the design of new anti-Alzheimer drugs

      PROTEINS-STRUCTURE FUNCTION AND GENETICS
    8. Slatkin, NE; Rhiner, M; Bolton, TM
      Donepezil in the treatment of opioid-induced sedation: Report of six cases

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    9. Giacobini, E
      Is anti-cholinesterase therapy of Alzheimer's disease delaying progression?

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    10. Thomas, A; Iacono, D; Bonanni, L; D'Andreamatteo, G; Onofrj, M
      Donepezil, rivastigmine, and vitamin E in Alzheimer disease: A combined P300 event-related potentials/neuropsychologic evaluation over 6 months

      CLINICAL NEUROPHARMACOLOGY
    11. Werber, EA; Rabey, JM
      The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

      JOURNAL OF NEURAL TRANSMISSION
    12. Pepeu, G
      Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    13. De Giorgio, R; Barbara, G; Stanghellini, V; Tonini, M; Vasina, V; Cola, B; Corinaldesi, R; Biagi, G; De Ponti, F
      Review article: the pharmacological treatment of acute colonic pseudo-obstruction

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    14. Bouaziz, H; Gentili, ME; Girard, F; Mazoit, JX; Benhamou, D; Laxenaire, MC; Fletcher, D
      Lack of peripheral analgesia mediated by intraplantar administration of neostigmine in carrageenan-injected rats

      EUROPEAN JOURNAL OF ANAESTHESIOLOGY
    15. Pakaski, M; Rakonczay, Z; Kasa, P
      Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C levelin vitro

      NEUROCHEMISTRY INTERNATIONAL
    16. Amenta, F; Parnetti, L; Gallai, V; Wallin, A
      Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?

      MECHANISMS OF AGEING AND DEVELOPMENT
    17. Holroyd, S; Shepherd, ML
      Alzheimer's disease: A review for the ophthalmologist

      SURVEY OF OPHTHALMOLOGY
    18. Oliveira-Silva, JJ; Alves, SR; Meyer, A; Perez, F; Sarcinelli, PD; Mattos, RD; Moreira, JC
      Influence of social-economic factors on the pesticine poisoning, Brazil

      REVISTA DE SAUDE PUBLICA
    19. Wessler, I; Roth, E; Schwarze, S; Weikel, W; Bittinger, F; Kirkpatrick, CJ; Kilbinger, H
      Release of non-neuronal acetylcholine from the human placenta: difference to neuronal acetylcholine

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    20. Brodaty, H; Ames, D; Boundy, KL; Hecker, J; Snowdon, J; Storey, E; Yates, MW
      Pharmacological treatment of cognitive deficits in Alzheimer's disease

      MEDICAL JOURNAL OF AUSTRALIA
    21. Grauer, E; Ben Nathan, D; Lustig, S; Kobiler, D; Kapon, J; Danenberg, HD
      Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors

      LIFE SCIENCES
    22. Irizarry, MC; Hyman, BT
      Alzheimer disease therapeutics

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    23. Yu, QS; Holloway, HW; Flippen-Anderson, JL; Hoffman, B; Brossi, A; Greig, NH
      Methyl analogues of the experimental Alzheimer drug phenserine: Synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action

      JOURNAL OF MEDICINAL CHEMISTRY
    24. Ros, E; Aleu, J; de Aranda, IG; Munoz-Torrero, D; Camps, P; Badia, A; Marsal, J; Solsona, C
      The pharmacology of novel acetylcholinesterase inhibitors, (+/-)-huprines Y and X, on the Torpedo electric organ

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Nordberg, A
      Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications

      BIOLOGICAL PSYCHIATRY
    26. Rogers, DC; Hagan, JJ
      5-HT6 receptor antagonists enhance retention of a water maze task in the rat

      PSYCHOPHARMACOLOGY
    27. Tariot, P; Winblad, B
      Galantamine, a novel treatment for Alzheimer's disease: A review of long-term benefits to patients and caregivers

      ALZHEIMER'S DISEASE
    28. Soreq, H; Seidman, S
      Anti-sense approach to anticholinesterase therapeutics

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    29. Lilienfeld, S; Parys, W
      Galantamine: Additional benefits to patients with Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    30. Korczyn, AD
      Muscarinic M1 agonists in the treatment of Alzheimer's disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    31. Kumar, V; Anand, R; Messina, J; Hartman, R; Veach, J
      An efficacy and safety analysis of Exelon (R) in Alzheimer's disease patients with concurrent vascular risk factors

      EUROPEAN JOURNAL OF NEUROLOGY
    32. Ormrod, D; Spencer, C
      Metrifonate - A review of its use in Alzheimer's disease

      CNS DRUGS
    33. Dooley, M; Lamb, HM
      Donepezil - A review of its use in Alzheimer's disease

      DRUGS & AGING
    34. Braida, D; Ottonello, F; Sala, M
      Eptastigmine restores the aged rat's normal cortical spectral power pattern

      PHARMACOLOGICAL RESEARCH
    35. Braida, D; Virag, W; Ottonello, F; Sala, M
      Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit

      PHARMACOLOGICAL RESEARCH
    36. Byrne, GJ
      Drug treatment in dementia

      CURRENT OPINION IN PSYCHIATRY
    37. Lev-Lehman, E; Evron, T; Broide, RS; Meshorer, E; Ariel, I; Seidman, S; Soreq, H
      Synaptogenesis and myopathy under acetylcholinesterase overexpression

      JOURNAL OF MOLECULAR NEUROSCIENCE
    38. Giacobini, E
      Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    39. Matthews, HP; Korbey, J; Wilkinson, DG; Rowden, J
      Donepezil in Alzheimer's disease: Eighteen month results from Southampton Memory Clinic

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    40. Grace, JB; Walker, MP; McKeith, IG
      A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    41. Giacobini, E
      Cholinesterase inhibitors stabilize Alzheimer disease

      NEUROCHEMICAL RESEARCH
    42. Shih, TM; McDonough, JH
      Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication

      ARCHIVES OF TOXICOLOGY
    43. Kasa, P; Papp, H; Kasa, P; Torok, I
      Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain

      NEUROSCIENCE
    44. Zhang, HY; Tang, XC
      Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells

      NEUROSCIENCE LETTERS
    45. Liu, J; Ho, WL; Lee, NTK; Carlier, PR; Pang, YP; Han, YF
      Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats

      NEUROSCIENCE LETTERS
    46. Giacobini, E
      Present and future of Alzheimer therapy

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    47. Dronfield, S; Egan, K; Marsden, CA; Green, AR
      Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat

      JOURNAL OF PSYCHOPHARMACOLOGY
    48. Ye, JW; Shang, YZ; Wang, ZM; Tang, XC
      Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance

      ACTA PHARMACOLOGICA SINICA
    49. Hauber, AB; Gnanasakthy, A; Mauskopf, JA
      Savings in the cost of caring for patients with Alzheimer's disease in Canada: An analysis of treatment with rivastigmine

      CLINICAL THERAPEUTICS
    50. Chaney, LA; Wineman, RW; Rockhold, RW; Hume, AS
      Acute effects of an insect repellent, N,N-diethyl-m-toluamide, on cholinesterase inhibition induced by pyridostigmine bromide in rats

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    51. Foy, JM; Starr, JM
      Assessment and treatment of dementia in medical patients

      PSYCHOTHERAPY AND PSYCHOSOMATICS
    52. Womer, DE; Shannon, HE
      Reversal of pertussis toxin-induced thermal allodynia by muscarinic cholinergic agonists in mice

      NEUROPHARMACOLOGY
    53. Zwart, R; van Kleef, RGDM; Gotti, C; Smulders, CJGM; Vijverberg, HPM
      Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs

      JOURNAL OF NEUROCHEMISTRY
    54. Hellstrom-Lindahl, E; Moore, H; Nordberg, Y
      Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists

      JOURNAL OF NEUROCHEMISTRY
    55. Ros, E; Aleu, J; Marsal, J; Solsona, C
      Effects of CI-1002 and CI-1017 on spontaneous synaptic activity and on thenicotinic acetylcholine receptor of Torpedo electric organ

      EUROPEAN JOURNAL OF PHARMACOLOGY
    56. Scott, LJ; Goa, KL
      Galantamine - A review of its use in Alzheimer's disease

      DRUGS
    57. Tsukada, H; Sato, K; Kakiuchi, T; Nishiyama, S
      Age-related impairment of coupling mechanism between neuronal activation and functional cerebral blood flow response was restored by cholinesterase inhibition: PET study with microdialysis in the awake monkey brain

      BRAIN RESEARCH
    58. Imbimbo, BP; Verdelli, G; Martelli, P; Marchesini, D
      Two-year treatment of Alzheimer's disease with eptastigmine

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    59. Al-Baggou, BK; Mohammad, FK
      Antagonism of methomyl-induced toxicosis by diphenhydramine in rats

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    60. Carrier, L
      Optimism in the treatment of Alzheimer's disease

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    61. van Reekum, R; Simard, M; Cohen, T
      The prediction and prevention of Alzheimer's disease - towards a research agenda

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    62. Chaney, LA; Rockhold, RW; Wineman, RW; Hume, AS
      Anticonvulsant-resistant seizures following pyridostigmine bromide (PB) and N,N-diethyl-m-toluamide (DEET)

      TOXICOLOGICAL SCIENCES
    63. Kurz, A
      The impact of antidementia drugs on real life

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    64. Fitten, LJ; Ortiz, F; Siembieda, DW; O'Neill, J; Halgren, E; Fisher, A
      Reduction of motoric agitation and restlessness by AF102B and tacrine in the macaque

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    65. Swanwick, GRJ; Lawlor, BA
      Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    66. Harvey, RJ
      A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    67. Yaqub, BA
      New horizons in management of Alzheimer's disease

      SAUDI MEDICAL JOURNAL
    68. Sun, QQ; Xu, SS; Pan, JL; Guo, HM; Cao, WQ
      Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students

      ACTA PHARMACOLOGICA SINICA
    69. Xu, SS; Cai, ZY; Qu, ZW; Yang, RM; Cai, YL; Wang, GQ; Sy, XQ; Zhong, XS; Cheng, RY; Xu, WA; Li, JX; Feng, B
      Huperzine-A in capsules and tablets for treating patients with Alzheimer disease

      ACTA PHARMACOLOGICA SINICA
    70. Wang, H; Carlier, PR; Ho, WL; Lee, NTK; Pang, YP; Han, YF
      Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor

      ACTA PHARMACOLOGICA SINICA
    71. Liu, J; Zhang, HY; Wang, LM; Tang, XC
      Inhibitory effects of huperzine B on cholinesterase activity in mice

      ACTA PHARMACOLOGICA SINICA
    72. Wang, XD; Zhang, JM; Yang, HH; Hu, GY
      Modulation of NMDA receptor by huperzine A in rat cerebral cortex

      ACTA PHARMACOLOGICA SINICA
    73. Shih, TM; McDonough, JH
      Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    74. Cousins, MS; Finn, M; Trevitt, J; Carriero, DL; Conlan, A; Salamone, JD
      The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    75. Moser, VC
      Comparison of aldicarb and methamidophos neurotoxicity at different ages in the rat: Behavioral and biochemical parameters

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    76. Snape, MF; Misra, A; Murray, TK; De Souza, RJ; Williams, JL; Cross, AJ; Green, AR
      A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066

      NEUROPHARMACOLOGY
    77. Kinney, GG; Patino, P; Mermet-Bouvier, Y; Starrett, JE; Gribkoff, VK
      Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    78. Francis, PT; Palmer, AM; Snape, M; Wilcock, GK
      The cholinergic hypothesis of Alzheimer's disease: a review of progress

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    79. McConnell, R; Pacheco, F; Wahlberg, K; Klein, W; Malespin, O; Magnotti, R; Akerblom, M; Murray, D
      Subclinical health effects of environmental pesticide contamination in a developing country: Cholinesterase depression in children

      ENVIRONMENTAL RESEARCH
    80. Burt, T; Sachs, GS; Demopulos, C
      Donepezil in treatment-resistant bipolar disorder

      BIOLOGICAL PSYCHIATRY
    81. O'Neill, J; Fitten, LJ; Siembieda, DW; Crawford, KC; Halgren, E; Fisher, A; Refai, D
      Divided attention-enhancing effects of AF102B and THA in aging monkeys

      PSYCHOPHARMACOLOGY
    82. Baumel, B
      Easing the burden of Alzheimer's disease: therapeutic options

      EUROPEAN JOURNAL OF NEUROLOGY
    83. Ivens, IA; Schmuck, G; Machemer, L
      Learning and memory of rats after long-term administration of low doses ofparathion

      TOXICOLOGICAL SCIENCES
    84. MEAGHER MW; ILLICH PA; SALINAS JA
      PHYSOSTIGMINES IMPACT ON BRIEF SHOCK-INDUCED HYPOALGESIA PARALLELS ITS EFFECT ON MEMORY

      Neurobiology of learning and memory (Print)
    85. MERCIER FJ; BENHAMOU D
      PROMISING NONNARCOTIC ANALGESIC TECHNIQUES FOR LABOR

      Bailliere's clinical obstetrics and gynaecology
    86. GIACOBINI E
      CHOLINERGIC FOUNDATIONS OF ALZHEIMERS-DISEASE THERAPY

      JOURNAL OF PHYSIOLOGY-PARIS
    87. LEBERT F; PASQUIER F; SOULIEZ L; PETIT H
      TACRINE EFFICACY IN LEWY BODY DEMENTIA

      International journal of geriatric psychiatry
    88. KNAPP M; WILKINSON D; WIGGLESWORTH R
      THE ECONOMIC CONSEQUENCES OF ALZHEIMERS-DISEASE IN THE CONTEXT OF NEWDRUG DEVELOPMENTS

      International journal of geriatric psychiatry
    89. STEIN RD; BACKMAN SB; COLLIER B; POLOSA C
      SYNAPTIC INHIBITORY EFFECTS OF EDROPHONIUM ON SYMPATHETIC GANGLIONIC TRANSMISSION

      Canadian journal of anaesthesia
    90. SCREMIN OU; SHIH TM; LI MG; JENDEN DJ
      MAPPING OF CEREBRAL METABOLIC-ACTIVATION IN 3 MODELS OF CHOLINERGIC CONVULSIONS

      Brain research bulletin
    91. KOJIMA J; ONODERA K
      NIK-247 INDUCES LONG-TERM POTENTIATION OF SYNAPTIC TRANSMISSION IN THE CA1 REGION OF RAT HIPPOCAMPAL SLICES THROUGH M-2 MUSCARINIC RECEPTORS

      General pharmacology
    92. ONEILL J; FITTEN LJ; SIEMBIEDA D; HALGREN E; KIM E; FISHER A; PERRYMAN K
      EFFECTS OF AF102B AND TACRINE ON DELAYED MATCH-TO-SAMPLE IN MONKEYS

      Progress in neuro-psychopharmacology & biological psychiatry
    93. JANN MW
      PRECLINICAL PHARMACOLOGY OF METRIFONATE

      Pharmacotherapy
    94. LIU J; ZHANG HY; TANG XC; WANG B; HE XC; BAI DL
      EFFECTS OF SYNTHETIC (-)-HUPERZINE-A ON CHOLINESTERASE ACTIVITIES ANDMOUSE WATER MAZE PERFORMANCE

      Zhongguo yaoli xuebao
    95. HU ZJ; JIANG HL; CHEN JZ; CHEN KX; JI RY
      ANALYSIS OF ELECTRONIC-STRUCTURES OF PHYSOSTIGMINE ANALOGS

      Zhongguo yaoli xuebao
    96. XIONG ZQ; CHENG DH; TANG XC
      EFFECTS OF HUPERZINE-A ON NUCLEUS BASALIS MAGNOCELLULARIS LESION-INDUCED SPATIAL WORKING-MEMORY DEFICIT

      Zhongguo yaoli xuebao
    97. WANG H; TANG XC
      ANTICHOLINESTERASE EFFECTS OF HUPERZINE-A, E2020, AND TACRINE IN RATS

      Zhongguo yaoli xuebao
    98. Rakonczay, Z; Kovacs, I
      Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer therapy

      ACTA BIOLOGICA HUNGARICA
    99. BRAIDA D; PALADINI E; GRIFFINI P; LAMPERTI M; COLIBRETTI L; SALA M
      LONG-LASTING ANTIAMNESIC EFFECT OF A NOVEL ANTICHOLINESTERASE INHIBITOR (MF268)

      Pharmacology, biochemistry and behavior
    100. PHILIPPENS IHCHM; BUSKER RW; WOLTHUIS OL; OLIVIER B; BRUIJNZEEL PLB; MELCHERS BPC
      SUBCHRONIC PHYSOSTIGMINE PRETREATMENT IN GUINEA-PIGS - EFFECTIVE AGAINST SOMAN AND WITHOUT SIDE-EFFECTS

      Pharmacology, biochemistry and behavior


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 13:43:32